<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Fairburn CG</submitter><funding>Wellcome Trust</funding><pagination>64-71</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4461007</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>70</volume><pubmed_abstract>Eating disorders may be viewed from a transdiagnostic perspective and there is evidence supporting a transdiagnostic form of cognitive behaviour therapy (CBT-E). The aim of the present study was to compare CBT-E with interpersonal psychotherapy (IPT), a leading alternative treatment for adults with an eating disorder. One hundred and thirty patients with any form of eating disorder (body mass index >17.5 to &lt;40.0) were randomized to either CBT-E or IPT. Both treatments involved 20 sessions over 20 weeks followed by a 60-week closed follow-up period. Outcome was measured by independent blinded assessors. Twenty-nine participants (22.3%) did not complete treatment or were withdrawn. At post-treatment 65.5% of the CBT-E participants met criteria for remission compared with 33.3% of the IPT participants (p &lt; 0.001). Over follow-up the proportion of participants meeting criteria for remission increased, particularly in the IPT condition, but the CBT-E remission rate remained higher (CBT-E 69.4%, IPT 49.0%; p = 0.028). The response to CBT-E was very similar to that observed in an earlier study. The findings indicate that CBT-E is potent treatment for the majority of outpatients with an eating disorder. IPT remains an alternative to CBT-E, but the response is less pronounced and slower to be expressed.&lt;h4>Current controlled trials&lt;/h4>ISRCTN 15562271.</pubmed_abstract><journal>Behaviour research and therapy</journal><pubmed_title>A transdiagnostic comparison of enhanced cognitive behaviour therapy (CBT-E) and interpersonal psychotherapy in the treatment of eating disorders.</pubmed_title><pmcid>PMC4461007</pmcid><funding_grant_id>046386</funding_grant_id><funding_grant_id>094585</funding_grant_id><funding_grant_id>079113/Z/06/Z</funding_grant_id><funding_grant_id>079113</funding_grant_id><pubmed_authors>O'Connor ME</pubmed_authors><pubmed_authors>Cooper Z</pubmed_authors><pubmed_authors>Basden S</pubmed_authors><pubmed_authors>Fairburn CG</pubmed_authors><pubmed_authors>Bailey-Straebler S</pubmed_authors><pubmed_authors>Doll HA</pubmed_authors><pubmed_authors>Jones R</pubmed_authors><pubmed_authors>Murphy R</pubmed_authors></additional><is_claimable>false</is_claimable><name>A transdiagnostic comparison of enhanced cognitive behaviour therapy (CBT-E) and interpersonal psychotherapy in the treatment of eating disorders.</name><description>Eating disorders may be viewed from a transdiagnostic perspective and there is evidence supporting a transdiagnostic form of cognitive behaviour therapy (CBT-E). The aim of the present study was to compare CBT-E with interpersonal psychotherapy (IPT), a leading alternative treatment for adults with an eating disorder. One hundred and thirty patients with any form of eating disorder (body mass index >17.5 to &lt;40.0) were randomized to either CBT-E or IPT. Both treatments involved 20 sessions over 20 weeks followed by a 60-week closed follow-up period. Outcome was measured by independent blinded assessors. Twenty-nine participants (22.3%) did not complete treatment or were withdrawn. At post-treatment 65.5% of the CBT-E participants met criteria for remission compared with 33.3% of the IPT participants (p &lt; 0.001). Over follow-up the proportion of participants meeting criteria for remission increased, particularly in the IPT condition, but the CBT-E remission rate remained higher (CBT-E 69.4%, IPT 49.0%; p = 0.028). The response to CBT-E was very similar to that observed in an earlier study. The findings indicate that CBT-E is potent treatment for the majority of outpatients with an eating disorder. IPT remains an alternative to CBT-E, but the response is less pronounced and slower to be expressed.&lt;h4>Current controlled trials&lt;/h4>ISRCTN 15562271.</description><dates><release>2015-01-01T00:00:00Z</release><publication>2015 Jul</publication><modification>2025-04-04T07:30:01.501Z</modification><creation>2019-03-27T01:53:09Z</creation></dates><accession>S-EPMC4461007</accession><cross_references><pubmed>26000757</pubmed><doi>10.1016/j.brat.2015.04.010</doi></cross_references></HashMap>